Skip to contentS
Sanara MedTech Inc.
S
SMTISanara MedTech Inc. Q3 2019 · 10-Q
Revenue$2.91M$2.91M+85.7% vs Q3 2018 Net Income-$836.98K-$836.98KN/M vs Q3 2018 EPS Diluted-$0.35-$0.35— vs Q3 2018 Gross Profit$2,624,118+80.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sanara MedTech Inc. · CIK 714256 · Engraved from SEC EDGAR
Operating Cash Flowderived-$94,314N/M Free Cash Flowderived-$235,967N/M Margins · derivedGross margin90.2%−2.4 pt vs Q3 2018
Operating margin-27.4%−19.0 pt vs Q3 2018
Net margin-28.8%−19.1 pt vs Q3 2018
ended Sep 30, 2019 · filed Nov 14, 2019 · 45 d after period end